Potential drug-drug interactions with mitogen-activated protein kinase (MEK) inhibitors used to treat melanoma.

A MaraniH GioacchiniM PaolinelliA OffidaniCampanati Anna

Published in: Expert opinion on drug metabolism & toxicology (2023)

Physicians should be aware about potential benefits, but also increased toxicity caused by drug interactions between MEK inhibitors and other drugs in the management of patients with metastatic melanoma.

Keyphrases

primary care
pi k akt
human health
oxidative stress
risk assessment
drug induced
signaling pathway
cell proliferation
climate change
oxide nanoparticles